ApoptosisB-LymphocytesExosomes
Dr. Michael J. Keating, MD
NPI1801980560
- Medicare services, 2016
- 240
- Part D claims, 2024
- 11
- Publications
- 941
- Clinical trials
- 2
- Hospital affiliations
- 1
- Practice address
- 603 South Chestnut, Ellensburg, WA 98926
- Practice phone
- Call (509) 962-9841
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Keating's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Michael J. Keating is a medical oncologist in Ellensburg, Washington
Dr. Keating practices at Kittitas Valley Healthcare in Ellensburg, Washington, part of Kittitas Valley Healthcare.
Dr. Keating's NPI, 1801980560, was assigned on October 3, 2006. Dr. Keating's Texas license number on file is E4447.
NPI and contact details
- NPI
- 1801980560NPI Registry (opens in a new tab)
- NPI enumeration date
- October 3, 2006
- NPI status
- Active
- Practice phone
- (509) 962-9841
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Male
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Affiliation Data
Dr. Michael J. Keating practices at Kittitas Valley Healthcare in Ellensburg, Washington
Dr. Keating's primary practice is Kittitas Valley Healthcare, at 603 South Chestnut, Ellensburg, WA 98926 in Kittitas County. The practice phone is (509) 962-9841.
- Kittitas Valley Healthcare603 South Chestnut, Ellensburg, WA 98926 · Kittitas CountyPhone(509) 962-9841
Source: Dmand AI Affiliation Data
Dr. Michael J. Keating is affiliated with 1 site of care
Dr. Keating's primary practice is Kittitas Valley Healthcare in Ellensburg, Washington, part of Kittitas Valley Healthcare.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Michael J. Keating's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Keating practices. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Kittitas Valley Healthcare | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Keating practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across Kittitas Valley Healthcare and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Michael J. Keating is one of 145 medical oncologists in Washington
Medical oncology is Dr. Keating's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Keating has a license on file in Texas.
Specialties and state licenses
- Medical oncology, TexasPrimary
Medical oncologists near Dr. Keating
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Michael J. Keating billed Medicare for 240 services in 2016
CMS data shows 240 Medicare services from Dr. Keating across 3 procedure codes in 2016, all of them office visits. Medicare paid $5,752 for them. Every service was in a facility, such as a hospital, rather than an office.
Medicare services, 2016240
Paid by Medicare$5,752
Procedure codes3
Dr. Keating compared with the Washington median for medical oncologists, 2016
- Dr. Keating
- Washington median
- Medicare services
- 240vs 36234% below
- Part D claims
- 27vs 18085% below
Medians across 131 medical oncologists in Washington with Dmand AI profiles that report each measure.
Dr. Keating's most billed Medicare procedure codes, 2016
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Keating?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Keating and other medical oncologists in Washington.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Michael J. Keating's patients have a median age of 74
Across all payers, Dmand AI patient panel data puts Dr. Keating's median patient age at 74, with 38% women.
Dr. Keating's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 74
Patient panel by sex, all payers
- Women38%
- Men63%
Source: Dmand AI Patient Panel Data
Dr. Michael J. Keating wrote 11 Medicare Part D claims in 2024
In 2024, Dr. Keating wrote 11 Medicare Part D claims. Every claim was for a generic drug. They cover 1 drug, with $258,581 in total drug cost. In 2018, CMS named 250 claims across 4 drugs.
Part D claims, 202411
Drugs named by CMS1
Total drug cost$258,581
Dr. Keating's most prescribed drugs by claims, 2019
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2018 to 2019
- 2018
- 2019
- Claims for drugs CMS names
- 2018: 2502019: 2789%
Drugs named by CMS: 1 in 2019, 4 in 2018.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
For MedTech and pharma teams
Find medical oncologists like Dr. Keating by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Michael J. Keating has 941 publications on record
Dmand AI links 941 papers to Dr. Keating, published from 2002 to 2025. 2016 was the busiest year, with 39. The most frequent topics are Leukemia, Lymphocytic, Chronic, B-Cell, Antineoplastic Combined Chemotherapy Protocols and Antineoplastic Agents. Dr. Keating has published most often in Blood. Dr. Keating's most frequent co-authors are Hagop M. Kantarjian, MD, Susan M. O'Brien, MD and William G. Wierda, MD, PhD.
Papers941
Years published2002 to 2025
Dr. Keating's papers by year, 2016 to 2025
Topics Dr. Keating writes about most
- Leukemia, Lymphocytic, Chronic, B-Cell
- Antineoplastic Combined Chemotherapy Protocols
- Antineoplastic Agents
- Leukemia, Myeloid, Acute
- Vidarabine
- Cytarabine
- Remission Induction
- Leukemia
Dr. Keating's most frequent co-authors
- Hagop M. Kantarjian, MD351 shared papers
- Susan M. O'Brien, MD285 shared papers
- William G. Wierda, MD, PhD244 shared papers
Recent publications by Dr. Keating
Cell Line, TumorCell ProliferationConserved Sequence
Blood Cancer J
Leukemia, Lymphocytic, Chronic, B-CellMicroRNAsMultigene Family
See who Dr. Keating researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Keating works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Michael J. Keating has worked on 2 clinical trials
Dmand AI links Dr. Keating to 2 clinical trials. Conditions studied include Leukemia, Lymphocytic, Chronic, B-Cell and Leukemia, B-Cell.
Clinical trials with Dr. Keating by phase
- NonePhase 1: no trials
- 1Phase 1/2: 1 trial
- 1Phase 2: 1 trial
- NonePhase 3: no trials
- NonePhase 4: no trials
Conditions in Dr. Keating's trials
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, B-Cell
Investigators on the most trials with Dr. Keating
- John C. Byrd, MD1 shared trial
- Danelle Frances James, MD1 shared trial
- Thomas J. Kipps, MD1 shared trial
Recent clinical trials with Dr. Keating
Multi-center Trial of Revlimid® and Rituximab, for First-Line Treatment of Chronic Lymphocytic Leukemia (CLL) (opens in a new tab)
Status unknownPhase 2
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellLenalidomide and Rituximab
A Phase I/II Trial of Idiotypic Vaccination for Chronic Lymphocytic Leukemia Using a Genetic Approach (opens in a new tab)
TerminatedPhase 1/2
Leukemia, Lymphocytic, Chronic, B-CellLeukemia, B-CellCLL vaccine using DNA plasmid vector
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Michael J. Keating received $60,872 in industry payments from 2016 to 2018
CMS Open Payments shows 36 general payments to Dr. Keating from 6 drug and device companies from 2016 to 2018. Consulting fees make up the largest share, 66% of the total. Genentech, Inc. paid the most, $33,780. It also lists 10 research payments totaling $13,247 in 2016.
General payments to Dr. Keating by program year, 2016 to 2018
General payments to Dr. Keating by kind, 2016 to 2018
$60.9Kin total
- Consulting fees$40,03066%
- Travel and lodging$19,77132%
- Food and beverage$1,0712%
Companies that paid Dr. Keating the most, 2016 to 2018
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Michael J. Keating has 1 award and honors on record
Dmand AI lists 1 award for Dr. Keating.
Awards and honors for Dr. Keating
- Undated
- Super Doc
Source: Dmand AI Professional Profile Data
Sources for Dr. Michael J. Keating's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Michael J. Keating
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Michael J. Keating's NPI number?
Dr. Michael J. Keating's NPI number is 1801980560. It was assigned on October 3, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Michael J. Keating?
Dr. Michael J. Keating is a medical oncologist in Ellensburg, Washington. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Michael J. Keating practice?
Dr. Keating practices at 603 South Chestnut, Ellensburg, WA 98926. Dr. Keating's primary practice is Kittitas Valley Healthcare in Ellensburg, Washington, part of Kittitas Valley Healthcare.
What is Dr. Michael J. Keating's office phone number?
The practice phone on file for Dr. Keating is (509) 962-9841.
What is Dr. Michael J. Keating's medical license number?
Dr. Keating's Texas license number on file is E4447.
Which hospitals is Dr. Michael J. Keating affiliated with?
Dr. Keating practices at Kittitas Valley Healthcare in Ellensburg, Washington.
Does Dr. Michael J. Keating accept Medicare?
Yes. CMS data shows Dr. Keating billed Medicare for 240 services in 2016.
What services does Dr. Michael J. Keating bill to Medicare?
In 2016, Dr. Keating's most billed Medicare services were office visit, established patient (99212), office visit, established patient (99214) and office visit, established patient (99213).
What drugs does Dr. Michael J. Keating prescribe most?
In 2019 Medicare Part D data, Dr. Keating's most prescribed drugs by claims were Imbruvica.
Has Dr. Michael J. Keating received payments from drug or device companies?
CMS Open Payments shows $60,872 in general payments to Dr. Keating from 6 companies from 2016 to 2018. The largest total came from Genentech, Inc.
Show 3 more questionsShow fewer questions
How long has Dr. Michael J. Keating been practicing?
Dr. Keating's NPI was assigned in 2006.
Does Dr. Michael J. Keating do research?
Dmand AI links 941 publications to Dr. Keating, published from 2002 to 2025. Dr. Keating has worked on 2 clinical trials.
Who does Dr. Michael J. Keating publish with?
Dr. Keating's most frequent co-authors are Hagop M. Kantarjian, MD (351 shared papers), Susan M. O'Brien, MD (285 shared papers) and William G. Wierda, MD, PhD (244 shared papers).
Selling to medical oncology practices?
See medical oncologists in Washington by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card